Objective To compare the efficacy of caffeine citrate and aminophylline in treatment of apnea of very low birth weight (VLBW) infants. Methods Totally 100 VLBW infants who were born and inhospitaled at our hospital during March 2013 to March 2015 were analyzed.48 VLBW infants during March 2013 to March 2014 were control group,52 VLBW infants during March 2014 to March 2015 were test group.The control group infants were given aminophylline during the treatment:a loading dose of 5 mg/kg for 30 minutes intravenous infusion,a dose of 2 mg/kg after 12 hours,and once every 12 hours.The test group infants were gave caffeine citrate treatment during the treatment:a loading dose of 20 mg/kg for intravenous infusion,a dose of 5 mg/kg after 24 hours,and once per day.The situations of incidence of apnea,duration of oxygen therapy,reaching full milk-feeding time,intravascular hemorrhage (IVH),necrotizing enterocolitis (NEC),retinopathy of prematurity (ROP),bronchopulmonary dysplasia (RPD) and mortality rate of two groups were compared. Results 1)Compared with the control group,the apnea incidence of test group's premature infants was decreased,and the difference was statistically significant(P<0.05);2)Compared with the control group,the test group had lower incidences of IVH,BPD,ROP and assisted ventilation rate,the differences were statistically significant [9(18.7%) vs 3(5.7%),χ2=3.98,P<0.05] ;[19(39.6%) vs 10(19.2%),χ2=5.05,P<0.05];[10(20.8%) vs 2(3.8%),χ2=6.85,P<0.05];3)The incidences of NEC,fatality,oxygen therapy,time to reach full milk-feeding,etc had no statistically significant differences between two groups (P>0.05); Conclusion Efficacy of caffeine citrate in prevention and treatment of premature infant apnea and its improving the prognosis of premature infants in the near future are better than those of aminophylline,but the outcome remains need further follow-up.
Key words
caffeine citrate /
apnea /
aminophylline /
very low birth weight infants
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 李文斌,常立文,刘伟,等.氨茶碱联合纳洛酮防治早产儿呼吸暂停与枸橼酸咖啡因疗效比较[J].中华实用儿科临床杂志,2014,29(18):1381-1384.
[2] 《中华儿科杂志》编辑委员会中华医学会儿科学分会新生儿学组.早产儿管理指南[J].中华儿科杂志,2006,44(3):188-191.
[3] 邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M].4版.北京:人民卫生出版社,2011:245-247.
[4] 杜立中.早产儿呼吸暂停的药物治疗[J].中国实用儿科杂志,2015,30(2):88-92.
[5] Bongianni F,Mutolo D,Cinelli E,et al.Respiratory responses induced by blockades of GABA and glycine receptors within the Botzinger complex and the pre- Botzinger complex of the rabbit[J].Brain Res,2010,1344(1):134-147.
[6] 赵婧,母得志.早产儿呼吸暂停诊治进展[J].临床儿科杂志,2012,30(3):291-294.
[7] 唐晓艳,王丹华.咖啡因在新生儿中的应用进展[J].中国新生儿科杂志,2014,29(5):343-346.
[8] 袁琳,陈超.咖啡因在新生儿中的临床应用[J].世界临床药物,2009,30(9):518-522.
[9] Schmidt B,Roberts RS,Davis P,et al.Long-term effects of caffeine therapy for apnea of prematurity[J].N Eng J Med,2007,357(19) :1893-1902.
[10] Erenberg A,Leff RD,Haack DG,et al.Caffeine citrate for the treatment of apnea of prematurity:a double-blind,placebo-con-trolled study[J].Pharmacotherapy,2000,20( 6) :644-652.
[11] Gray PH,Flenady VJ,Charles BG,et al.Caffeine citrate for very preterm infants:effects on development,temperament and behavior[J].J Paediatr Child Health,2011,47 ( 4) :167-172.
[12] Clark RH,Bloom BT,Spitzer AR,et a1.Reported medication use in the neonatal intensive care unit:data from a large national data set[J].Pediatrics,2006,117(3):1979-1987.
[13] New drug application:CAFCIT(NDA)020793[Z].Washington,DC:Food and DrugAdministration,2000.
[14] 许景林,林贵第,吴联强,等.枸橼酸咖啡因对原发性呼吸暂停早产儿的疗效研究[J].中国小儿急救医学,2015,22(4):262-265.
[15] 徐景武,武兆磊,陈泳涛,等.枸橼酸咖啡因治疗早产儿呼吸暂停临床应用观察[J].中国新生儿科杂志,2015,30(3):215-217.